Scholars Central

Conference abstractPublished 20 Jun 2016

Development and characterization of different solid lipid nanocarriers loaded with tamoxifen citrate/ coenzyme Q10 biotherapy for treatment of breast cancer

Authors: Eman Saddar Inbrahim El-Leithy, Rania S Abdel-Rashid

Helwan University, Egypt; MSA University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nanotechnology based combinatorial therapy has emerged as an effective strategy for cancer treatment due to anticancer synergistic activity, reduction of drug-related toxicity, suppression of multi-drug resistance and overcoming biomedical barriers against successful delivery of anticancer drugs. Tamoxifen citrate (TC) and coenzyme Q10 (CoQ10) loaded into different types of solid lipid nanocarriers (SLNs) were developed for delivering anticancer/antioxidant drug biotherapy into cancerous cells. Stearic acid (2% w/v) and poloxamer 188 (3%w/v) were selected as optimal lipid matrix and surfactant, respectively for developing biotherapy SLNs. Particle size, polydispersity index (PDI) and zeta potential were 266 nm, 0.741 and -27.5 mv, respectively while, the % encapsulation efficiency (%EE) of TC and CoQ10 were 87% and 38%, respectively. Incorporation of lecithin into lipid matrix has significantly reduced particle size and increased %EE of CoQ10 to 45%. Nanostructured lipid carriers (NLC1) decreased particle size to 81nm and increased %EE to 94% and 56% for TC and CoQ10, respectively. Lipid nanocapsules (LNC2) showed significant effect on decreasing both particle size to 36 nm and %EE to 48% and 30% for TC and CoQ10, respectively. All lipid nanocarriers offered controlled drugs release profiles. Formulations contain phospholipid (SLN11 and NLC1) showed good fitness to Higuchi model with prominent controlling effect for NLC1. Lipid nanocarriers significantly improved TC/CoQ10 permeation through intestinal mucosa with a prominent efficacy to formula SLN11. The study greatly suggests use of TC/CoQ10 solid lipid nanocarriers as potential delivery systems in breast cancer treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Eman Saddar Inbrahim El-Leithy”
  • BylineArticles whose byline prints “Rania S Abdel-Rashid”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels